Moderna slips after Citi downgrades MRNA to sell
Moderna shares fell 6.2% to $190.89 premarket after Citigroup downgraded MRNA to "sell" from "neutral"; Citi raised its price target to $80 from $60.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.